RC118
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RC118, covering 2025-01-27 to 2025-01-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]